雜志介紹

Rheumatology International雜志介紹

《Rheumatology International》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱國(guó)際風(fēng)濕病學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-RHEUMATOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.2，最新CiteScore 指數(shù)為7.3。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review

  Author: Huang, Gang; Wu, Lingfeng; Mei, Zhujun; Yao, Dongyuan

• Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys

  Author: Tanaka, Yoshiya; Barrett, Claire; Hirano, Yuji; Ikeda, Kei; Paizis, Kathy; Sameshima, Azusa; Mountian, Irina; Wong, Priscilla C.

• Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis

  Author: Ren, Jiaqi; Ding, Yanling; Zhao, Jinxia; Sun, Yongchang

• Bibliometric and altmetric analyses of publication activity in the field of idiopathic inflammatory myopathy in 2011-2021 based on web of science core collection databases

  Author: Li, Mengxiang; Yin, Feng; He, Youxian; Zhang, Xue; Yu, Hao; Yang, Qiuyu; Xie, Xintong; Wei, Guangliang; Chen, Huidong; He, Chengsong; He, Yue; Chen, Jie

英文介紹

Rheumatology International雜志英文介紹

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.

RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.